Surge in Cannabis Smuggling Prompts Thailand to Tighten Rules
Thailand aims to clamp down on easy access to cannabis by mandating medical prescriptions amid rising instances of tourists attempting to smuggle out large quantities of weed.
Dispensaries will be allowed to sell cannabis only to those with licenses or with prescriptions from medical professionals, including traditional medicine practitioners, when proposed changes to existing rules take effect in about 40 days. The amount sold will also be limited to 30 days of use, according to the Ministry of Public Health.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
15 hours ago
- Bloomberg
Effort to Ease Cannabis Rules Faces New Opposition From Experts
A Harvard addiction scientist and a former government lawyer are urging the US Department of Justice to reject a plan that would ease federal restrictions on cannabis, which the industry has been counting on to grow their businesses. In a new paper published Wednesday in JAMA Psychiatry, the authors argue that the Biden administration's push to reclassify cannabis relied on flawed reasoning and downplayed health risks, including cannabis-use disorder and links to psychosis.
Yahoo
a day ago
- Yahoo
3 Asian Penny Stocks With Market Caps Larger Than US$100M
Amidst ongoing trade tensions and fluctuating economic indicators, Asian markets have been a focal point of global investor attention. Penny stocks, often seen as smaller or newer companies with lower price points, continue to offer intriguing opportunities for growth. Despite their vintage-sounding name, these stocks can still present significant value when backed by strong financials and fundamentals. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.10 SGD42.5M ★★★★★★ Lever Style (SEHK:1346) HK$1.16 HK$731.9M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.06 HK$1.72B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.23 HK$2.05B ★★★★★★ Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.31 SGD9.09B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.184 SGD36.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.14 SGD861.46M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.56 HK$52.24B ★★★★★★ Click here to see the full list of 1,148 stocks from our Asian Penny Stocks screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shanghai Bio-heart Biological Technology Co., Ltd. (SEHK:2185) is a company focused on developing and commercializing innovative medical devices for cardiovascular diseases, with a market cap of HK$905.51 million. Operations: Shanghai Bio-heart Biological Technology Co., Ltd. does not report specific revenue segments. Market Cap: HK$905.51M Shanghai Bio-heart Biological Technology, with a market cap of HK$905.51 million, remains pre-revenue while focusing on innovative medical devices for cardiovascular diseases. The company has effectively managed its liabilities, with short-term assets significantly exceeding both short and long-term liabilities. Despite being unprofitable, it has reduced losses by 20.7% annually over five years and maintains a debt-free status. Recent developments include the successful enrollment in a Japanese trial for its sirolimus drug-coated balloon product, which may offer advantages over existing treatments due to its anti-inflammatory properties and prolonged drug release capabilities. However, high share price volatility persists amidst these advancements. Dive into the specifics of Shanghai Bio-heart Biological Technology here with our thorough balance sheet health report. Gain insights into Shanghai Bio-heart Biological Technology's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Tian An China Investments Company Limited is an investment holding company that focuses on investing in, developing, and managing properties in the People's Republic of China, Hong Kong, and the United Kingdom with a market cap of HK$6.52 billion. Operations: The company's revenue is primarily derived from its healthcare segment, which generated HK$1.58 billion, followed by property investment at HK$583.52 million and property development at HK$520.46 million, with additional income from other operations amounting to HK$327.21 million. Market Cap: HK$6.52B Tian An China Investments is navigating financial challenges, reporting a net loss of HK$207.08 million for 2024, down from a profit the previous year. Despite seasoned management and strong asset coverage over liabilities, the company faces hurdles with declining revenues in property sales due to market downturns and lack of new project handovers. Its debt is well-managed with cash flow covering interest payments effectively, yet it remains unprofitable with increasing losses over five years. The recent dividend decrease reflects these financial strains as the company trades significantly below its estimated fair value amidst industry volatility. Click here to discover the nuances of Tian An China Investments with our detailed analytical financial health report. Evaluate Tian An China Investments' historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Digital China Holdings Limited is an investment holding company that offers big data products and solutions to government and enterprise customers in Mainland China, with a market cap of HK$5.56 billion. Operations: The company's revenue is primarily derived from three segments: CN¥3.24 billion from big data products and solutions, CN¥5.52 billion from software and operating services, and CN¥7.96 billion from traditional and localization services. Market Cap: HK$5.56B Digital China Holdings is grappling with financial challenges, posting a net loss of CN¥253.95 million for 2024, though this marks an improvement from the previous year's larger deficit. The company's short-term assets comfortably cover both its short and long-term liabilities, and it maintains a solid cash position relative to debt. Despite these strengths, profitability remains elusive due to ongoing losses in associates and impairments on investments. Management's tenure is experienced; however, the board's limited experience could pose governance challenges. A proposed dividend suggests some confidence in future prospects despite current unprofitability. Click here and access our complete financial health analysis report to understand the dynamics of Digital China Holdings. Explore historical data to track Digital China Holdings' performance over time in our past results report. Take a closer look at our Asian Penny Stocks list of 1,148 companies by clicking here. Interested In Other Possibilities? Explore 22 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2185 SEHK:28 and SEHK:861. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
From September, Singapore mandates measles shots for helpers in homes with unvaccinated kids
SINGAPORE, June 11 — From September 1, all domestic helpers in Singapore working in homes with children under the age of seven who are not fully vaccinated against measles must themselves be immunised, the country's Ministry of Manpower (MOM) announced yesterday. The move is aimed at safeguarding 'unvaccinated young children who are at higher risk of serious health complications from measles infections', said MOM, as reported by Channel News Asia (CNA). Singapore has already recorded 10 measles infections in 2025 as of the week ending May 10, just one shy of the total 11 cases reported in all of 2024, according to the Ministry of Health. Employers applying for or renewing work permits for migrant domestic workers (MDWs) must now declare: Whether the domestic helper is already vaccinated or immune to measles Whether all children under seven in the household are fully vaccinated If unvaccinated, whether a vaccination appointment has been booked Domestic helpers may be exempted if they are already immune — either through previous infection or past vaccination — or if all children under seven in the home have been fully immunised. Proof of immunity, such as vaccination records or serology test results, may be required. Employers are advised to check their domestic helper's immunity status well before permit renewal. Households with immunocompromised members are also strongly encouraged to verify their helper's measles immunity or arrange for vaccination. To meet the requirement, domestic helpers must receive two doses of the MMR (measles, mumps, and rubella) vaccine, spaced at least 28 days apart. The vaccine is available at private GP clinics, with the cost to be paid by employers. MOM also warned against false declarations. 'If employers with children below seven years old are found with MDWs who are not immune against measles, their work pass privileges may be suspended until vaccination proof is submitted,' the ministry said. Random checks and documentary audits will be conducted to ensure compliance. While Singapore maintains high overall vaccination rates — over 95 per cent for the first MMR dose and 90 per cent for the second among resident two-year-olds — sporadic cases are expected, MOM said, citing the 'highly transmissible nature of the disease'. The Communicable Diseases Agency (CDA) stressed that despite strong local immunity, 'the surge in measles cases globally and regionally continues to pose public health risks, particularly for those without measles immunity'. Measles, which spreads through airborne droplets, has been part of Singapore's compulsory childhood immunisation schedule since 1985.
